Page 53 - GPD-4-3

Gene & Protein in Disease NLRP3 in SCI and CHM

doi: 10.1016/j.bbadis.2014.10.005 activation. Metabolism. 2014;63(5):693-701.
98. Szkudelska K, Szkudelski T. Resveratrol, obesity and doi: 10.1016/j.metabol.2014.02.003
diabetes. Eur J Pharmacol. 2010;635(1-3):1-8.
104. Jiang W, Hu X, Chen Y, et al. Esveratrol inhibits NLRP3
doi: 10.1016/j.ejphar.2010.02.054 inflammasome activation in rabbits with spinal cord injury.
J Cell Physiol. 2020;25(8):850.
99. Liu C, Shi Z, Fan L, Zhang C, Wang K, Wang B. Resveratrol
improves neuron protection and functional recovery in rat doi: 10.1002/jcp.24903
model of spinal cord injury. Brain Res. 2011;1374:100-109.
105. Ganeshpurkar A, Saluja AK. The pharmacological potential
doi: 10.1016/j.brainres.2010.11.061 of rutin. Saudi Pharm J. 2017;25(2):149-164.
100. Xu L, Botchway BO, Zhang S, Zhou J, Liu X. Inhibition of doi: 10.1016/j.jsps.2016.04.025
NF-κB signaling pathway by resveratrol improves spinal 106. Frutos MJ, Rincón-Frutos L, Valero-Cases E. Rutin.
cord injury. Front Neurosci. 2018;12:690.
Nonvitamin and Nonmineral Nutritional Supplements.
doi: 10.3389/fnins.2018.00690 Netherlands: Elsevier; 2019. p. 111-117.
101. Fu S, Lv R, Wang L, Hou H, Liu H, Shao S. Resveratrol, an 107. Wu J, Maoqiang L, Fan H, et al. Rutin attenuates
antioxidant, protects spinal cord injury in rats by suppressing neuroinflammation in spinal cord injury rats. J Surg Res.
MAPK pathway. Saudi J Biol Sci. 2018;25(2):259-266. 2016;203(2):331-337.
102. Jiang L, Zhang L, Kang K, et al. Resveratrol ameliorates doi: 10.1016/j.jss.2016.02.041
LPS-induced acute lung injury via NLRP3 inflammasome 108. Hung WL, Ho CT, Pan MH. Targeting the NLRP3
modulation. Biomed Pharmacother. 2016;84:130-138.
inflammasome in neuroinflammation: Health promoting
doi: 10.1016/j.biopha.2016.09.020 effects of dietary phytochemicals in neurological disorders.
Mol Nutr Food Res. 2020;64(4):1900550.
103. Yang SJ, Lim Y. Resveratrol ameliorates hepatic
metaflammation and inhibits NLRP3 inflammasome doi: 10.1002/mnfr.201900550

Volume 4 Issue 3 (2025) 11 doi: 10.36922/gpd.4827